Jianxin Ma Selected Research

Survivin

8/2014

Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repair.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianxin Ma Research Topics

Disease

11	Neoplasms (Cancer) 02/2024 - 09/2011
9	Hypoxia (Hypoxemia) 03/2015 - 09/2011
6	Esophageal Squamous Cell Carcinoma 03/2015 - 11/2013
4	Inflammation (Inflammations) 01/2024 - 01/2017
3	COVID-19 01/2023 - 01/2021
3	Carcinoma (Carcinomatosis) 06/2014 - 09/2011
2	Infections 04/2024 - 08/2011
2	Polyploidy 01/2022 - 01/2010
2	Esophageal Neoplasms (Esophageal Cancer) 10/2014 - 03/2014
1	Neuroinflammatory Diseases 10/2023
1	Neuralgia (Stump Neuralgia) 10/2023
1	Ascites 09/2023
1	Body Weight (Weight, Body) 09/2023
1	Hepatocellular Carcinoma (Hepatoma) 09/2023
1	Sepsis (Septicemia) 01/2023
1	Heart Failure 01/2023
1	Ischemia 01/2022
1	Atrophy 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Enteritis 01/2022
1	Genetic Translocation (Chromosomal Translocation) 11/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2021
1	Chronic Hepatitis B 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Necrosis 01/2017
1	Hepatitis B 10/2015
1	Genomic Instability 03/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2015
1	Squamous Cell Carcinoma of Head and Neck 10/2014
1	Prostatic Neoplasms (Prostate Cancer) 05/2014

Drug/Important Bio-Agent (IBA)

8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2023 - 09/2011
5	Proteins (Proteins, Gene)FDA Link 09/2023 - 01/2010
3	CytokinesIBA 01/2024 - 01/2022
3	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 10/2014
3	BerberineIBA 05/2014 - 11/2013
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2021
2	Interleukin-6 (Interleukin 6)IBA 09/2023 - 01/2017
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2022 - 11/2021
1	Neutralizing AntibodiesIBA 04/2024
1	NLR ProteinsIBA 01/2024
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2024
1	InterleukinsIBA 01/2024
1	p38 Mitogen-Activated Protein KinasesIBA 10/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2023
1	GPR39-C3IBA 10/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2023
1	Class A Scavenger ReceptorsIBA 09/2023
1	Oxidants (Oxidizing Agents)IBA 09/2023
1	OzoneIBA 09/2023
1	EnzymesIBA 09/2023
1	MetalloproteinsIBA 09/2023
1	Interferon-gamma (Interferon, gamma)IBA 09/2023
1	ImmunosorbentsIBA 09/2023
1	AlbuminsIBA 01/2023
1	AerosolsIBA 01/2023
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023
1	Monoterpenes (Monoterpenoids)IBA 01/2022
1	pinaneIBA 01/2022
1	GlycosidesIBA 01/2022
1	peoniflorinIBA 01/2022
1	1-Propanol (Propanol)IBA 10/2021
1	N 30IBA 10/2021
1	AcetoneIBA 10/2021
1	Volatile Organic CompoundsIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	nutlin 3IBA 01/2018
1	Glutathione (Reduced Glutathione)IBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	CollagenIBA 01/2017
1	AcidsIBA 01/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	Transaminases (Aminotransferases)IBA 01/2017
1	Bile Acids and Salts (Bile Acids)IBA 01/2017
1	BilirubinIBA 01/2017
1	Laminin (Merosin)IBA 01/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2015
1	MicroRNAs (MicroRNA)IBA 03/2015
1	statticIBA 03/2015
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2015
1	Caspase 3 (Caspase-3)IBA 01/2015
1	Bortezomib (Velcade)FDA Link 01/2015
1	triptolideIBA 10/2014
1	Bee Venoms (Bee Venom)IBA 10/2014
1	Melitten (Melittin)IBA 10/2014
1	NSC 74859IBA 10/2014
1	CaspasesIBA 10/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2014
1	SurvivinIBA 08/2014
1	sepantroniumIBA 08/2014
1	ginsenoside Rg3IBA 06/2014
1	Inhibitor of Apoptosis ProteinsIBA 03/2014
1	LCL161IBA 03/2014
1	Caspase 8 (Caspase-8)IBA 03/2014

Therapy/Procedure

9	Radiotherapy 01/2022 - 11/2013
6	Therapeutics 02/2024 - 10/2014
1	Critical Care (Surgical Intensive Care) 01/2023
1	Length of Stay 01/2023
1	Intraperitoneal Injections 10/2014
1	Chemoradiotherapy 03/2014